Abstract
Anti-HIV-1 envelope broadly neutralizing monoclonal antibodies (bNAbs) isolated from memory B cells may not fully represent HIV-1-neutralizing profiles measured in plasma. Accordingly, we characterized near-pan-neutralizing antibodies extracted directly from the plasma of two “elite neutralizers.” Circulating anti-gp120 polyclonal antibodies were deconvoluted using proteomics to guide lineage analysis of bone marrow plasma cells. In both subjects, a single lineage of anti-CD4-binding site (CD4bs) antibodies explained the plasma-neutralizing activity. Importantly, members of these lineages potently neutralized 89%–100% of a multi-tier 117 pseudovirus panel, closely matching the specificity and breadth of the circulating antibodies. X-ray crystallographic analysis of one monoclonal, N49P7, suggested a unique ability to bypass the CD4bs Phe43 cavity, while reaching deep into highly conserved residues of Layer 3 of the gp120 inner domain, likely explaining its extreme potency and breadth. Further direct analyses of plasma anti-HIV-1 bNAbs should provide new insights for developing antibody-based antiviral agents and vaccines. An HIV-neutralizing antibody achieves near-pan-neutralizing activity through recognition of a highly conserved, difficult-to-access region of the viral gp120 glycoprotein.
Original language | English |
---|---|
Pages (from-to) | 1783-1795.e14 |
Journal | Cell |
Volume | 173 |
Issue number | 7 |
DOIs | |
State | Published - 14 Jun 2018 |
Externally published | Yes |
Keywords
- HIV-1
- antibody
- broadly neutralizing antibody
- humoral immunity
- pan-neutralization
- repertoire